Royal Philips (PHG) announced the expanded commercial availability of LumiGuide 3D Device Guidance, the world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy, across Europe and the United States. LumiGuide represents a breakthrough in radiation-free* navigation, allowing physicians to visualize and guide devices inside the body using light instead of continuous X-ray. Announced at RSNA 2025, the wider commercial rollout marks the next step in Philips’ long-term commitment to improving radiation safety and dose reduction in image-guided therapy.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- Philips unveils BlueSeal Horizon, a new 3.0T MRI platform
- Philips launches Verida, a CT powered by AI
- Philips launches Philips Image Management 15
- Philips, Cortechs.ai extend partnership to advance quantitative neuroimaging
- Philips introduces DeviceGuide, AI-powered device tracking solution